The heterozygous dominant mutation in the CASR gene and the homozygous recessive mutation in the SLC12A3 gene in this patient represent the molecular genetic basis for the co-occurrence of FHH and GS. Here, SLC12A3 is linked to familial hypocalciuric hypercalcemia.